Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Advanced Liquid Level Detection with Tecan’s Cavro® Omni Robot
Thursday, May 22, 2014
Offers ‘hybrid’ liquid sensing, provides exceptional process security and full traceability.

New 20µl Liquidator 96 from Anachem
Thursday, May 22, 2014
Maximizes users workflow with fast, 96-well pipetting and no complex programming.

Next-Generation Flow Cytometry Instrument Broadens Analysis in Life Science Research
Thursday, May 22, 2014
Life Technologies Attune NxT Acoustic Focusing Cytometer expands capabilities, features modular design to fit any lab’s budget and research.

New Pipette Skins Deliver A Fun, New Way to Personalize Pipettes in the Lab
Thursday, May 22, 2014
MyPipette Skins - Easy to apply, clean and remove.

Hepregen Launches First Rat Hepatopac™ Assay Kit
Thursday, May 22, 2014
Application-directed kit complements its human kit counterpart.

XEI Scientific Awarded Patent for New TEM Stage Loader
Wednesday, May 21, 2014
Company has been granted a new US patent # US8716676B2 on May 6, 2014.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

A 30 Year Partnership with Agar Scientific
Friday, May 16, 2014
Long-standing relationship helps Dr Young throughout a research career spanning rheumatoid arthritis, ocular degeneration.

Malvern Publishes New Whitepaper that Explores AQbD
Friday, May 16, 2014
The whitepaper is freely available for download from http://www.malvern.com/beyond_sops.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 2573
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv